Acute myeloid leukaemia after treatment with razoxane.
Two new cases of acute myeloid leukaemia occurring after razoxane therapy are recorded and further haematological and cytogenetic details of two cases previously reported are described. The need for long-term follow-up after patients discontinue razoxane therapy is emphasized.
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy; D011929:Razoxane / Q000009:adverse effects* / Q000627:therapeutic use
D010879:Piperazines; D011929:Razoxane